P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.

Rayid Abdulqawi, Rachel Dockry, Kimberley Holt, Gary Layton, Bruce G. McCarthy, Anthony P. Ford, Jaclyn A. Smith

Division of Immunology, Immunity to Infection and Respiratory Medicine

Research output: Contribution to journal › Article › peer-review

1 results
- Title(descending)

Cough monitoring system facilitates clinical trials and enables development of treatments for patients with refractory chronic cough
Jacky Smith (Participant), Kevin Mcguinness (Participant) & Ashley Woodcock (Participant)
Impact: Health and wellbeing, Economic